APLM (APLM) Stock Price & Analysis
APLM (APLM) fell 1.03% to USD 18.21 as of July 25, 2026 at 13:42 UTC, according to Nexqual real-time market data.
APLM last closed at USD 18.4; the session ranged USD 17.8–18.28 on volume of 13,026 shares. Market capitalization is $39.99M, with a 52-week range of USD 3.66–42.12 (NCM). Source: Nexqual, July 25, 2026 at 13:42 UTC.
Key Statistics (as of July 25, 2026 at 13:42 UTC)
| Price | USD 18.21 |
|---|---|
| Change | ▼ 1.03% (down) |
| Previous Close | USD 18.4 |
| Open | USD 17.8 |
| Day Range | USD 17.8 – 18.28 |
| 52-Week Range | USD 3.66 – 42.12 |
| Volume | 13,026 shares |
| Market Cap | $39.99M |
| Exchange | NCM |
Technical Analysis (APLM)
Nexqual's technical model rates APLM "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 13:42 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.28 (neutral) |
| vs SMA50 | Above (USD 16.74) |
| MACD | 0.4 (positive) |
Analyst Ratings (APLM)
Wall Street analysts rate APLM "None", per Nexqual as of July 25, 2026 at 13:42 UTC.
| Consensus Rating | None |
|---|
Earnings (APLM)
Source: Nexqual, July 25, 2026 at 13:42 UTC.
Financials & Fundamentals (APLM)
| Total Revenue | $8.84M |
|---|---|
| Gross Margin | +100.00% |
| Operating Margin | +431.87% |
| Profit Margin | -123.72% |
| ROE | -1305.37% |
| Current Ratio | 0.96 |
| Total Cash | $3.28M |
| Total Debt | $643,000 |
| Free Cash Flow | $-9.81M |
Source: Nexqual, July 25, 2026 at 13:42 UTC.
Financial Health Score (APLM)
Nexqual rates APLM's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:42 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $3M cash, no debt |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Critical — ROE -1305%, ROA -57.6% |
Ownership (APLM)
| Insider Ownership | +47.10% |
|---|---|
| Institutional Ownership | +0.06% |
| Shares Outstanding | 2.20M |
| Float | 1.24M |
| Short % of Float | +0.89% |
Source: Nexqual, July 25, 2026 at 13:42 UTC.
Leadership (APLM)
APLM is led by Hung-Wen Chen (age 64), CEO & Chairman of the Board, per Nexqual as of July 25, 2026 at 13:42 UTC.
| CEO & Chairman of the Board | Hung-Wen Chen (age 64) |
|---|---|
| Chief Financial Officer | K. H. Lin C.A.I.A. (age 55) |
| Director & COO | Yi-Kuei Chen (age 55) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.12 | ▼ 1.69% |
| ICU | SeaStar Medical Holding Corpora | USD 3.75 | ▼ 3.6% |
| BGLC | BioNexus Gene Lab Corp | USD 1.51 | ▼ 1.95% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:42 UTC. This page is informational and not investment advice.